Literature DB >> 3972914

Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia.

D K Dastur.   

Abstract

A review and a reappraisal are presented of earlier data on cerebral circulatory and metabolic studies in normal active elderly men (Group I) of mean age 71 years, compared with normal young subjects of mean age 21 years, conducted at the National Institutes of Health, Bethesda, MD, U.S.A., during 1956-1958. There was no significant difference in the mean CBF and cerebral metabolic rate for oxygen (CMRO2) values between the two populations; i.e., these important parameters did not fall with chronological aging per se. There was significant depression in the mean cerebral metabolic rate for glucose (CMRG) value (by approximately 23%) in the aged compared with the young. Newer methods using positron emission tomography and appropriate isotopes have confirmed these findings in normal aging in human subjects and experimental animals. As expected, MABP and cerebral vascular resistance (CVR) were significantly elevated in the normal aged. MABP was even more elevated in elderly hypertensive subjects, and the CVR more elevated in the subjects with arteriosclerosis (Group II), who also showed a small but significant fall in CBF and in internal jugular venous PO2. The CBF showed a more pronounced fall in senile aged patients with chronic brain syndrome (Group III), in whom the CMRO2 also showed a marked drop (by approximately 22%); the CMRG fell still further (approximately 40% of that in the young). Of the few aged subjects followed up after a lapse of 11 years by a repeat estimation of the same physiological and psychological parameters and of the EEG, most showed clear worsening, together with a fall in overall physical and intellectual performance, probably related to a rise in CVR and an increase in atherosclerosis with aging.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972914     DOI: 10.1038/jcbfm.1985.1

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  17 in total

1.  Reply to Biskup et al. and Tu et al.: Sex differences in metabolic brain aging.

Authors:  Manu S Goyal; Andrei G Vlassenko; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

2.  Aerobic glycolysis in the human brain is associated with development and neotenous gene expression.

Authors:  Manu S Goyal; Michael Hawrylycz; Jeremy A Miller; Abraham Z Snyder; Marcus E Raichle
Journal:  Cell Metab       Date:  2014-01-07       Impact factor: 27.287

Review 3.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

4.  PET in Cerebrovascular Disease.

Authors:  William J Powers; Allyson R Zazulia
Journal:  PET Clin       Date:  2010-01-01

Review 5.  Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

Authors:  Levi W Evans; Matthew S Stratton; Bradley S Ferguson
Journal:  Nat Prod Rep       Date:  2020-01-29       Impact factor: 13.423

6.  Brain aerobic glycolysis functions and Alzheimer's disease.

Authors:  Andrei G Vlassenko; Marcus E Raichle
Journal:  Clin Transl Imaging       Date:  2014-12-10

Review 7.  Effects of hypoperfusion in Alzheimer's disease.

Authors:  Benjamin P Austin; Veena A Nair; Timothy B Meier; Guofan Xu; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Vivek Prabhakaran
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Loss of Brain Aerobic Glycolysis in Normal Human Aging.

Authors:  Manu S Goyal; Andrei G Vlassenko; Tyler M Blazey; Yi Su; Lars E Couture; Tony J Durbin; Randall J Bateman; Tammie L-S Benzinger; John C Morris; Marcus E Raichle
Journal:  Cell Metab       Date:  2017-08-01       Impact factor: 27.287

9.  Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; S Tsuji; N Shuke; H Sumiya; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1993-05

Review 10.  Age-related changes in cerebral oxidative metabolism. Implications for drug therapy.

Authors:  S Hoyer
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.